Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

Jay Achar

11 та иш

Médecins sans Frontières, Manson Unit, London, UK

  1. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

    James M. Trauer, Jay Achar, Nargiza Parpieva +7

    МақолаTuberculosis Research and EpidemiologyBMC Medicine20163 иқтибос
    ABI

  2. Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan

    Shona Horter, Beverley Stringer, Nell Gray +5

    МақолаTuberculosis Research and EpidemiologyBMC Infectious Diseases20203 иқтибос
    ABI

  3. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan

    Johanna Kuhlin, Chris Smith, Atadjan Khaemraev +8

    МақолаTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20181 иқтибос
    ABI

  4. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

    S.K. Abidi, Jay Achar, M.M. Assao Neino +34

    МақолаTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 иқтибос
    ABI

  5. Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

    Philipp du Cros, Atadjan Khamraev, Zinaida Tigay +15

    МақолаTuberculosis Research and EpidemiologyERJ Open Research20201 иқтибос
    ABI

  6. Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan

    Shona Horter, Jay Achar, Nell Gray +4

    МақолаTuberculosis Research and EpidemiologyPLoS ONE20201 иқтибос
    ABI

  7. Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen

    Jay Achar, Catherine Berry, Krzysztof Herboczek +7

    БошқаTuberculosis Research and EpidemiologyEmerging infectious diseases20150 иқтибос
    ABI

  8. Accuracy of molecular drug susceptibility testing amongst tuberculosis patients in Karakalpakstan, Uzbekistan

    Horacio Gil, Hasmik Margaryan, I. Azamat +8

    МақолаTuberculosis Research and EpidemiologyTropical Medicine & International Health20210 иқтибос
    ABI

  9. Effectiveness and Safety of Modified Fully Oral Nine-Month Treatment Regimens for Rifampicin-Resistant Tuberculosis: Prospective Cohort Study

    Oleksandr Korotych, Jay Achar, Elmira Gurbanova +23

    ПрепринтTuberculosis Research and EpidemiologySSRN Electronic Journal20240 иқтибос
    ABI

  10. A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020

    Michael L. Rekart, Phone Thit, Modupe Oluya +14

    Шарҳ мақолаTuberculosis Research and EpidemiologyIJTLD OPEN20240 иқтибос
    ABI

  11. Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis

    Anthony J. Garcia‐Prats, Maria Garcia‐Cremades, Vivian Cox +97

    Шарҳ мақолаTuberculosis Research and EpidemiologyThe Lancet Child & Adolescent Health20250 иқтибос
    ABI